ScinoPharm Taiwan, Ltd. (1789.TW)

TWD 18.75

(3.88%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 11.72 Billion 11.91 Billion 11.69 Billion 11.84 Billion 11.67 Billion 12.56 Billion
Total Current Assets 6.38 Billion 6.32 Billion 5.96 Billion 5.91 Billion 5.4 Billion 6.5 Billion
Cash And Short Term Investments 3.94 Billion 4.34 Billion 4.13 Billion 4.08 Billion 3.48 Billion 4.38 Billion
Cash and Cash Equivalents 3.94 Billion 4.29 Billion 4.08 Billion 4.05 Billion 3.3 Billion 4.2 Billion
Short Term Investments 8.3 Million 51.13 Million 50.71 Million 34.31 Million 175.14 Million 179.02 Million
Net Receivables 813.45 Million 653.54 Million 393.04 Million 472.93 Million 670.45 Million 662.97 Million
Inventory 1.51 Billion 1.18 Billion 1.34 Billion 1.24 Billion 1.12 Billion 1.36 Billion
Other Current Assets 105.79 Million 785.78 Million 96.85 Million 108.07 Million 131.68 Million 760 Million
Total Non-Current Assets 5.34 Billion 5.59 Billion 5.72 Billion 5.93 Billion 6.26 Billion 6.05 Billion
Net PPE 4.57 Billion 4.79 Billion 4.88 Billion 4.84 Billion 5.1 Billion 4.75 Billion
Good Will And Intangible Assets 19.15 Million 9.95 Million 8.79 Million 8.9 Million 14.06 Million 16.75 Million
Good Will - - - - - -
Intangible Assets 19.15 Million 9.95 Million 8.79 Million 8.9 Million 14.06 Million 16.75 Million
Long-Term Investments 92.6 Million 92.42 Million 164.35 Million 303.07 Million 269.34 Million 318.36 Million
Tax Assets 640.93 Million 637.43 Million 614.97 Million 602.97 Million 606.12 Million 593.1 Million
Other Non Current Assets 10.69 Million 53.68 Million 53.22 Million 175.04 Million 271.5 Million 370.09 Million
Other Assets - - - - - -
Total Liabilities 1.35 Billion 1.46 Billion 1.18 Billion 1.31 Billion 1.41 Billion 2.02 Billion
Total Current Liabilities 729.45 Million 803.09 Million 556.31 Million 686.64 Million 741.74 Million 1.94 Billion
Account Payables 101.27 Million 125.26 Million 69.69 Million 159.67 Million 101.01 Million 89.39 Million
Tax Payables 62.59 Million 99.63 Million 71.16 Million 67.96 Million 1000.00 65.37 Million
Short Term Debt 50.87 Million 96.72 Million 17.33 Million 27.16 Million 251.36 Million 1.41 Billion
Deferred Revenue 110.96 Million 67.75 Million 70.56 Million 66.84 Million 55.98 Million 65.37 Million
Other Current Liabilities 466.33 Million 513.35 Million 398.72 Million 432.96 Million 333.37 Million 377.93 Million
Total Non Current Liabilities 627.7 Million 658.02 Million 623.8 Million 630.71 Million 672.87 Million 78.65 Million
Long-Term Debt 570.23 Million 581.18 Million 540.26 Million 550.18 Million 590.02 Million -
Deferred Revenue Non Current 54.51 Million - 79.54 Million - 82.18 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.29 Million 76.84 Million 3.64 Million 80.53 Million 87 Thousand 78.57 Million
Other Liabilities - - - - - -
Total Equity 10.36 Billion 10.45 Billion 10.51 Billion 10.52 Billion 10.25 Billion 10.53 Billion
Stock Holders Equity 10.36 Billion 10.45 Billion 10.51 Billion 10.52 Billion 10.25 Billion 10.53 Billion
Common Stock 7.9 Billion 7.9 Billion 7.9 Billion 7.9 Billion 7.9 Billion 7.9 Billion
Retained Earnings 494.88 Million 565.43 Million 657.98 Million 658.27 Million 490.34 Million 708.33 Million
Accumulated other comprehensive income 667.46 Million 682.53 Million 650.99 Million 669.04 Million 616.52 Million 685.51 Million
Common Stock Equity 10.36 Billion 10.45 Billion 10.51 Billion 10.52 Billion 10.25 Billion 10.53 Billion
Capital Lease Obligation 587.78 Million 599.07 Million 556.43 Million 566.68 Million 606.03 Million -
Total Investments 100.91 Million 143.55 Million 215.06 Million 337.38 Million 444.48 Million 497.38 Million
Total Debt 621.1 Million 677.9 Million 557.6 Million 577.34 Million 841.38 Million 1.41 Billion
Net Debt -3.32 Billion -3.61 Billion -3.52 Billion -3.47 Billion -2.46 Billion -2.79 Billion

Balance Sheet Charts